These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29683980)

  • 21. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
    Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
    Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
    Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study.
    Liu J; Zhao J; Zhang Y; Ji Y; Lin S; Dun G; Guo S
    J Ultrasound Med; 2017 Feb; 36(2):285-293. PubMed ID: 28039877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B.
    Ciftciler R; Ozenirler S; Yucel AA; Cengiz M; Erkan G; Buyukdemirci E; Sönmez C; Esendaglı GY
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27925300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Lang S; Kütting F; Staub A; Schramowski J; Schramm C; Kasper P; Goeser T; Steffen HM; Demir M
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1235-1240. PubMed ID: 28885276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
    Ito K; Kuno A; Ikehara Y; Sugiyama M; Saito H; Aoki Y; Matsui T; Imamura M; Korenaga M; Murata K; Masaki N; Tanaka Y; Hige S; Izumi N; Kurosaki M; Nishiguchi S; Sakamoto M; Kage M; Narimatsu H; Mizokami M
    Hepatology; 2012 Oct; 56(4):1448-56. PubMed ID: 22535703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
    Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
    J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
    Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
    Shin WG; Park SH; Jang MK; Hahn TH; Kim JB; Lee MS; Kim DJ; Jun SY; Park CK
    Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
    Li J; Mao RC; Li XL; Zheng JW; Qi X; Yuan Q; Zhang J; Zhang JM; Xia NS
    Dig Liver Dis; 2018 May; 50(5):482-489. PubMed ID: 29396134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Ceylan B; Fincanci M; Yardimci C; Eren G; Tözalgan Ü; Müderrisoğlu C; Paşaoğlu E
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):606-12. PubMed ID: 23325286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.